News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
865,699 Results
Type
Article (87671)
Company Profile (824)
Press Release (777189)
Multimedia
Podcasts (182)
Webinars (28)
Section
Business (233154)
Career Advice (4142)
Deals (39827)
Drug Delivery (143)
Drug Development (91326)
Employer Resources (203)
FDA (18329)
Job Trends (17412)
News (397625)
Policy (39941)
Tag
Academia (3006)
Academic (2)
Accelerated approval (22)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (157)
Alzheimer's disease (1742)
Antibody-drug conjugate (ADC) (287)
Approvals (18409)
Artificial intelligence (559)
Autoimmune disease (123)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (182)
Biotechnology (487)
Bladder cancer (143)
Brain cancer (58)
Breast cancer (556)
Cancer (4436)
Cardiovascular disease (397)
Career advice (3564)
Career pathing (39)
CAR-T (267)
CDC (58)
Cell therapy (736)
Cervical cancer (34)
Clinical research (76212)
Collaboration (1534)
Company closure (4)
Compensation (1019)
Complete response letters (64)
COVID-19 (2970)
CRISPR (92)
C-suite (697)
Cystic fibrosis (145)
Data (5416)
Decentralized trials (2)
Denatured (66)
Depression (125)
Diabetes (484)
Diagnostics (7146)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (261)
Drug pricing (204)
Drug shortages (36)
Duchenne muscular dystrophy (216)
Earnings (99854)
Editorial (58)
Employer branding (25)
Employer resources (173)
Events (134216)
Executive appointments (1008)
FDA (21074)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1390)
Gene editing (199)
Generative AI (56)
Gene therapy (600)
GLP-1 (1072)
Government (5411)
Grass and pollen (8)
Guidances (378)
Healthcare (20941)
HIV (54)
Huntington's disease (43)
IgA nephropathy (79)
Immunology and inflammation (269)
Immuno-oncology (27)
Indications (69)
Infectious disease (3235)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (109)
Intellectual property (208)
Interviews (816)
IPO (17938)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (87)
Layoffs (651)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (628)
Lymphoma (313)
Machine learning (35)
Management (66)
Manufacturing (713)
MASH (164)
Medical device (14949)
Medtech (14987)
Mergers & acquisitions (22848)
Metabolic disorders (1258)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (294)
Neuropsychiatric disorders (78)
Neuroscience (2891)
NextGen: Class of 2025 (7703)
Non-profit (5099)
Now hiring (60)
Obesity (599)
Opinion (322)
Ovarian cancer (149)
Pain (176)
Pancreatic cancer (191)
Parkinson's disease (261)
Partnered (33)
Patents (450)
Patient recruitment (372)
Peanut (58)
People (66535)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23511)
Phase II (33075)
Phase III (24933)
Pipeline (3552)
Policy (314)
Postmarket research (3554)
Preclinical (10626)
Press Release (72)
Prostate cancer (221)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (744)
Real estate (7432)
Recruiting (80)
Regulatory (28383)
Reports (65)
Research institute (2710)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (16)
RSV (81)
Schizophrenia (144)
Series A (225)
Series B (170)
Service/supplier (30)
Sickle cell disease (87)
Special edition (26)
Spinal muscular atrophy (173)
Sponsored (43)
Startups (4322)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (96)
The Weekly (114)
Vaccines (1083)
Venture capital (74)
Weight loss (421)
Women's health (73)
Worklife (21)
Date
Today (192)
Last 7 days (440)
Last 30 days (3440)
Last 365 days (33419)
2025 (31235)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (83)
Alaska (7)
Arizona (319)
Arkansas (14)
Asia (51209)
Australia (9003)
California (10542)
Canada (3100)
China (1004)
Colorado (442)
Connecticut (474)
Delaware (306)
Europe (117785)
Florida (1542)
Georgia (340)
Hawaii (3)
Idaho (68)
Illinois (870)
India (60)
Indiana (507)
Iowa (21)
Japan (357)
Kansas (130)
Kentucky (40)
Louisiana (28)
Maine (81)
Maryland (1379)
Massachusetts (7827)
Michigan (332)
Minnesota (612)
Mississippi (6)
Missouri (131)
Montana (34)
Nebraska (27)
Nevada (115)
New Hampshire (81)
New Jersey (2894)
New Mexico (32)
New York (2826)
North Carolina (1511)
North Dakota (10)
Northern California (4927)
Ohio (321)
Oklahoma (22)
Oregon (51)
Pennsylvania (2155)
Puerto Rico (20)
Rhode Island (47)
South America (1656)
South Carolina (59)
South Dakota (1)
Southern California (4050)
Tennessee (162)
Texas (1646)
United States (38436)
Utah (316)
Vermont (1)
Virginia (268)
Washington D.C. (85)
Washington State (886)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
There are 865,699 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Brain cancer
Imvax Heads to FDA With 6-Month Survival Gain in Glioblastoma, Despite Endpoint Miss
While Imvax’s autologous immunotherapy IGV-001 missed the primary endpoint of progression-free survival in a Phase IIb trial, the company will request a meeting with the FDA to discuss next steps for “synergistic” treatment.
December 2, 2025
·
2 min read
·
Dan Samorodnitsky
Alzheimer’s disease
I Remember Aduhelm. The Return of Roche in Alzheimer’s Is a Turning Point
After covering the Alzheimer’s space through every high and low,
BioSpace
’s Annalee Armstrong welcomes back Roche for the 2026 Alzheimer’s Renaissance.
December 2, 2025
·
2 min read
·
Annalee Armstrong
Alzheimer’s disease
Roche Is Back in Alzheimer’s as Latest Antibody Clears Amyloid Plaques
Trontinemab lowered amyloid levels below the threshold of positivity in 92% of treated patients.
December 2, 2025
·
2 min read
·
Tristan Manalac
Vaccines
ACIP To Discuss Hep B, Childhood Vaccine Schedule Under New Chair Who Linked COVID Shots to Cancer
This week’s meeting of the Advisory Committee on Immunization Practices will be led by Kirk Milhoan, a physician and pastor who recently claimed that COVID-19 vaccines contained a contamination that causes cancer.
December 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
QurAlis to Present Data From its Phase 1 Clinical Trial of QRL-101, a Potential Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener, at American Epilepsy Society 2025 Annual Meeting
December 2, 2025
·
2 min read
Press Releases
enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness
December 2, 2025
·
9 min read
Press Releases
Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for Plozasiran in Severe Hypertriglyceridemia
December 2, 2025
·
7 min read
Press Releases
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025
December 2, 2025
·
4 min read
Press Releases
NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call
December 2, 2025
·
4 min read
Press Releases
Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD
December 2, 2025
·
4 min read
1 of 86,570
Next
